Comparison tool

Compare peptides

Pick up to three compounds. Useful for deciding whether two peptides in a stack actually do different things, or whether you're paying twice for the same pathway.

Select up to three (1/3)

Comparison results

Attribute
CategoryLongevity
Evidence gradeModerate
Also known asElamipretide, MTP-131
MechanismConcentrates in the inner mitochondrial membrane where it binds cardiolipin, stabilising cristae architecture, improving electron-transport efficiency and reducing reactive oxygen species leakage.
Key benefitsImproved mitochondrial ATP output · Reduced oxidative stress markers · Fatigue improvement in mitochondrial disease trials
Side effectsInjection-site reactions are common and can be significant · Headache · Dizziness
Half-lifeRoughly 2 hours
AdministrationDaily subcutaneous injection
Dosing overviewTrial dosing around 40 mg daily; community protocols use less
StorageRefrigerate; protect from light
Legal statusInvestigational drug, not approved for general use.

Dosing figures reflect published literature and commonly reported community protocols. They are informational only.

Head-to-head comparisons

Each comparison below is its own page with the full attribute table, key differences and shared attributes for that pairing. They are grouped by the category the compounds are indexed under.

GLP-1 receptor agonists

Direct comparisons between the incretin-based compounds most often searched against one another.

Recovery and tissue repair

Pairings between compounds indexed for healing, connective tissue and post-injury recovery.

Growth-hormone axis

Secretagogues and releasing peptides that act on growth-hormone signalling, compared with each other and with adjacent compounds.

Longevity and mitochondrial

Compounds indexed under longevity, cellular and mitochondrial function.

Cognitive and nootropic

Peptides indexed for cognition and mood-related use.

Sexual health

Melanocortin and related compounds indexed for sexual-health use.